Skip to main content

Peer Review reports

From: The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

Original Submission
28 Jun 2020 Submitted Original manuscript
30 Jun 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
2 Jul 2020 Editorially accepted
14 Jul 2020 Article published 10.1186/s13063-020-04576-9

You can find further information about peer review here.

Back to article page